Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T18:22:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; no study data, eligibility criteria, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:30:33.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 in the page header, indicating a backend/template change. No substantive study content, eligibility criteria, or results are affected by this update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T23:20:05.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-15T10:31:17.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Locations section reorganized; a unified 'Locations' header was added and state-level site entries updated (Arizona, California, Colorado, Kentucky, Michigan, Minnesota, Nebraska, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Wisconsin).
    Difference
    1%
    Check dated 2025-12-17T20:18:20.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:51:23.000Z thumbnail image

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.